Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bob Merold Joins Symphony Metreo as General Manager of New Pharmaceutical Division.


Former IMS Health IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow.  Executive to Deliver Ground-Breaking Business Performance Management Solutions for the Pharmaceutical Industry

PALO ALTO Palo Alto, city, California
Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries.
, Calif. -- Symphony symphony [Gr.,=sounding together], a sonata for orchestra.

The Italian operatic overture, called sinfonia, was standardized by Alessandro Scarlatti at the end of the 17th cent.
 Metreo, Inc., a leading provider of enterprise pricing, operations management Operations management is an area of business that is concerned with the production of goods and services, and involves the responsibility of ensuring that business operations are efficient and effective.  and performance management solutions, today announced creation of a new Pharmaceutical Division and the addition of Bob Merold as its General Manager.

Merold will be responsible for applying Symphony Metreo's world class capabilities to create new solutions that increase sales and lower costs. Symphony Metreo offers enterprise decision support solutions widely used by multi-national companies in the distribution, manufacturing and packaged goods Noun 1. packaged goods - groceries that are packaged for sale
foodstuff, grocery - (usually plural) consumer goods sold by a grocer

plural, plural form - the form of a word that is used to denote more than one
 industries. Merold brings more than two decades of experience in information management and technology serving the global pharmaceutical industry.

"Business leaders in pharmaceuticals are facing unprecedented challenges in driving the performance of their companies, and the resulting complexities are stretching their internal IT teams to their limits. Our team, solutions and technology will help enable our clients to meet these challenges by improving their insights and making better decisions without additional burdens to IT," said Tal Ball, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Symphony Metreo. "Bob's work has gained the trust and respect of many of the most important companies in pharma, and as we launch into this new industry, his leadership and understanding of market dynamics will be incredible assets. Bob's passion for pharma, combined with his proven business strategy and team management skills will put Symphony Metreo at a great advantage in this market."

Pharmaceutical companies face increasingly complex business challenges that are exacerbated by extremely large volumes of data and the need to integrate many disparate data sources. Leveraging Symphony Metreo's unique, world class capabilities, pharmaceutical companies will benefit from being able to quickly develop solutions that enable better decision making - driving sales growth and cost efficiencies.

Merold joins Symphony Metreo to spearhead the launch of its new pharmaceutical unit and related business development efforts after serving as an industry expert for the Symphony Technology Group (STG stg abbr (= sterling) → ester ) for four years. As a senior executive at IMS Health in the 1990's, Bob developed and grew to market leadership the most widely used information service in the industry, the Xponent suite of products, in both America and Europe. Prior to IMS Health, Merold held management positions at Procter & Gamble and Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were . Over the past decade he's consulted for numerous data and technology companies and venture capital firms Name Location Founding date Managing Partners/Directors Specialty Capital managed
5AM Ventures Menlo Park, CA; Waltham, MA 2002 John Diekman, PhD (managing partner), Scott Rocklage, PhD (managing partner), Andrew Schwab (managing partner) life sciences $200M [1]
, in the process working with virtually every major multi-national pharmaceutical firm.

"Having consulted with Symphony for four years, I know the pharmaceutical industry has never had anything remotely close to what Symphony Metreo will offer. We are building a broad range of new solutions across every commercial function, ranging the spectrum from new analytics, improved forecasting, superior micro marketing, more efficient sales operations and managed care contracting," Merold said.

About Symphony Metreo

Symphony Metreo helps organizations meet their financial goals of Revenue and Margin with innovative solutions that align align (līn),
v to move the teeth into their proper positions to conform to the line of occlusion.
 and synchronize See synchronization.  top-down planning with bottom-up execution by focusing on the strategic levers of Price, Volume and Cost. Symphony Metreo serves global enterprises with innovative award winning applications in the areas of Enterprise Pricing, Operations Management and Performance Management. Headquartered in Palo Alto, Calif., Symphony Metreo is owned by the Symphony Technology Group, a $2.1 billion strategic holding company. For additional information, visit http://www.symphony-metreo.com.

Copyright [c] 2008 Symphony Metreo, Inc. All Rights Reserved. All other brand names, product names, or trademarks belong to their respective holders.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 24, 2008
Words:565
Previous Article:ORBCOMM Announces Agreement with Largest Canadian Wireless Carrier.
Next Article:Yingli Green Energy will Supply PV Modules to Largest University Campus Solar Energy Facility in the United States.
Topics:



Related Articles
personalia.
PUTTING THE POP BACK IN CHRISTMAS.
London Symphony Orchestra and Takeda Pharmaceutical Company Launch the 7th Takeda Global Concert Series.
Holidays at the symphony.
Two Eugene Symphony musicians perform on Grammy-nominated recordings.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles